CHANG Yue, WU Yue, GUO Jianfeng, et al. Hypoglycemic Effects and Myocardial Protection of Sanghuangporus vaninii Polysaccharide on Diabetes Rats[J]. Science and Technology of Food Industry, 2025, 46(2): 358−366. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024020037.
Citation: CHANG Yue, WU Yue, GUO Jianfeng, et al. Hypoglycemic Effects and Myocardial Protection of Sanghuangporus vaninii Polysaccharide on Diabetes Rats[J]. Science and Technology of Food Industry, 2025, 46(2): 358−366. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024020037.

Hypoglycemic Effects and Myocardial Protection of Sanghuangporus vaninii Polysaccharide on Diabetes Rats

More Information
  • Received Date: February 02, 2024
  • Available Online: November 09, 2024
  • To examine the hypoglycemic effects and myocardial protection of Sanghuangporus vaninii polysaccharide (SP) in T2DM rats, these effects were assessed in rats fed a high glucose and high fat diet combined with streptozotocin (STZ). The rats were randomly assigned to one of the following six groups: the diabetes mellitus (DM), metformin (MET), low-, medium-, and high-dose SP (SPL, SPM, and SPH), and control (CN) groups. Following 4 weeks of continuous intervention by gavage, the weights and multiple physiological and biochemical indicators of rats were measured and recorded, and performed pathological observations of the pancreatic and myocardial tissues of rats. Results revealed that SP at all assessed doses could reduce weight loss in T2DM rats compared to the DM group, significantly reduce fasting blood glucose and serum insulin levels, and improve glucose tolerance (P<0.01 or P<0.05). With an increase in the dosage of SP, serum total cholesterol (TC), triglyceride (TG), and low density lipoprotein cholesterol (LDL-C) levels in the SP-fed rats reduced (P<0.01 or P<0.05), whereas no significant changes in high-density lipoprotein cholesterol (HDL-C). Furthermore, there was a significant reduction in lactate dehydrogenase (LDH) activity (P<0.01), an upregulation of total superoxide dismutase (SOD) and catalase (CAT) activities (P<0.01 or P<0.05), and a significant reduction in malondialdehyde (MDA) content (P<0.01). Additionally, the SPM and SPH treatments reduced the levels of interleukin-1β (IL-1β) and interleukin-6 (IL-6) in rat myocardial tissues. HE staining revealed a significant increase in the number of pancreatic islet cells in SP group rats than in the DM group rats, and the cells were more complete. Compared with the DM group, the myocardial tissue showed uniform cell gaps and reduced vacuolization after SP intervention, with the SPH group exhibiting the most significant improvement. In summary, SP can protect the structure of pancreatic and cardiac tissues, regulate blood sugar levels, reduce blood lipid contents, reduce insulin resistance, and have anti-diabetic effects in T2DM rats.
  • loading
  • [1]
    戴玉成, 崔宝凯. 药用真菌桑黄种类研究[J]. 北京林业大学学报,2014,36(5):1−7. [DAI Y C, CUI B K. Progress on the species of medicinal fungus Inonotus sanghuang[J]. Journal of Beijing Forestry University,2014,36(5):1−7.]

    DAI Y C, CUI B K. Progress on the species of medicinal fungus Inonotus sanghuang[J]. Journal of Beijing Forestry University, 2014, 36(5): 1−7.
    [2]
    王雨阳, 李正鹏, 陈万超, 等. 栽培地域和木屑对瓦尼桑黄子实体化学成分及生物活性的影响[J]. 食用菌学报,2023,30(6):76−85. [WANG Y Y, LI Z P, CHEN W C, et al. Effects of cultivation area and sawdust type on chemical composition and biological activities of Sanghuangporus vaninii fruiting bodies[J]. Acta Edulis Fungi,2023,30(6):76−85.]

    WANG Y Y, LI Z P, CHEN W C, et al. Effects of cultivation area and sawdust type on chemical composition and biological activities of Sanghuangporus vaninii fruiting bodies[J]. Acta Edulis Fungi, 2023, 30(6): 76−85.
    [3]
    LIN G L, LI Y Y, CHEN X H, et al. Extraction, structure and bioactivities of polysaccharides from Sanghuangporus spp.:A review[J]. Food Bioscience,2023,53:102587. doi: 10.1016/j.fbio.2023.102587
    [4]
    刘震, 侯万超, 牛华周, 等. 桑黄中黄嘌呤氧化酶抑制剂的筛选分离及质谱分析[J]. 中国食品添加剂,2023,34(12):8−17. [LIU Z, HOU W C, NIU H Z, et al. Screening, separation and mass spectrometry analysis of xanthine oxidase inhibitors in Phellinus igniarius[J]. China Food Additives,2023,34(12):8−17.]

    LIU Z, HOU W C, NIU H Z, et al. Screening, separation and mass spectrometry analysis of xanthine oxidase inhibitors in Phellinus igniarius[J]. China Food Additives, 2023, 34(12): 8−17.
    [5]
    HUANG J, WANG K, ZUO S, et al. Unsaturated fatty acid promotes the production of triterpenoids in submerged fermentation of Sanghuangporus baumii[J]. Food Bioscience,2020,37:100712. doi: 10.1016/j.fbio.2020.100712
    [6]
    ZHANG J J, CHEN B S, DAI H Q, et al. Sesquiterpenes and polyphenols with glucose-uptake stimulatory and antioxidant activities from the medicinal mushroom Sanghuangporus sanghuang[J]. Chinese Journal of Natural Medicines,2021,19(9):693−699. doi: 10.1016/S1875-5364(21)60101-2
    [7]
    祝梓旋, 张诗浩, 田兴, 等. 瓦尼桑黄核苷类成分的液体发酵工艺优化及其细胞毒活性[J]. 华中师范大学学报(自然科学版),2023,57(6):878−889. [ZHU Z X, ZHANG S H, TIAN X, et al. Optimization of liquid fermentation and cytotoxic activity of nucleosides from Sanghuangporus vaninii[J]. Joural of Central China Normal University (Nat. Sci),2023,57(6):878−889.]

    ZHU Z X, ZHANG S H, TIAN X, et al. Optimization of liquid fermentation and cytotoxic activity of nucleosides from Sanghuangporus vaninii[J]. Joural of Central China Normal University (Nat. Sci), 2023, 57(6): 878−889.
    [8]
    徐伟芳, 白国法, 杜佳慧, 等. 不同来源桑黄菌种的鉴定及主要化学成分比较[J]. 蚕学通讯,2023,43(1):27−35. [XU W F, BAI G F, DU J H, et al. Species identification of Sanghuang strains differing in origin and comparison of main chemical components[J]. Newsletter of Sericultural Science,2023,43(1):27−35.] doi: 10.3969/j.issn.1006-0561.2023.01.004

    XU W F, BAI G F, DU J H, et al. Species identification of Sanghuang strains differing in origin and comparison of main chemical components[J]. Newsletter of Sericultural Science, 2023, 43(1): 27−35. doi: 10.3969/j.issn.1006-0561.2023.01.004
    [9]
    吴声华, 戴玉成. 药用真菌桑黄的种类解析[J]. 菌物学报,2020,39(5):781−794. [WU S H, DAI Y C. Species clarification of the medicinal fungus Sanghuang[J]. Mycosystema,2020,39(5):781−794.]

    WU S H, DAI Y C. Species clarification of the medicinal fungus Sanghuang[J]. Mycosystema, 2020, 39(5): 781−794.
    [10]
    侯伟男, 朝克吐, 图力古尔. 蒙古桑黄——中国桑黄孔菌属一新种[J]. 菌物学报,2023,42(4):874−882. [HOU W N, CHAO K T, TU L G E. A new species of Sanghuangporus (Hymenochaetales, Basidiomycota) from Inner Mongolia of China[J]. Mycosystema,2023,42(4):874−882.]

    HOU W N, CHAO K T, TU L G E. A new species of Sanghuangporus (Hymenochaetales, Basidiomycota) from Inner Mongolia of China[J]. Mycosystema, 2023, 42(4): 874−882.
    [11]
    XIA Y J, YANG C Y, LIU X F, et al. Enhancement of triterpene production via in situ extractive fermentation of Sanghuangporus vaninii YC-1[J]. Biotechnology and Applied Biochemistry,2022,69(6):2561−2572. doi: 10.1002/bab.2305
    [12]
    宋吉玲. 杨树桑黄中活性成分及抗痛风作用机制研究[D]. 长春:长春师范大学, 2023. [SONG J L. Studies on the active constituents and anti-gout mechanism of Sanghuangporus vaninii[D]. Changchun:Changchun Normal University, 2023.]

    SONG J L. Studies on the active constituents and anti-gout mechanism of Sanghuangporus vaninii[D]. Changchun: Changchun Normal University, 2023.
    [13]
    杨焱, 陈晓华, 戴玉成, 等. 我国桑黄产业发展现状、问题及展望:桑黄产业发展千岛湖宣言[J]. 菌物学报,2023,42(4):855−873. [YANG Y, CHEN X H, DAI Y C, et al. Sanghuang industry in China:current status, challenges and perspectives:the Qiandao Lake declaration for sanghuang industry development[J]. Mycosystema,2023,42(4):855−873.]

    YANG Y, CHEN X H, DAI Y C, et al. Sanghuang industry in China: current status, challenges and perspectives: the Qiandao Lake declaration for sanghuang industry development[J]. Mycosystema, 2023, 42(4): 855−873.
    [14]
    张诗泉, 郭毓菲, 汪芷玥, 等. 茯苓液体发酵培养条件优化[J]. 食品工业,2020,41(4):135−138. [ZHANG S Q, GUO Y F, WANG Z Y, et al. Optimization of fermentation conditions for Poria cocos[J]. The Food Industry,2020,41(4):135−138.]

    ZHANG S Q, GUO Y F, WANG Z Y, et al. Optimization of fermentation conditions for Poria cocos[J]. The Food Industry, 2020, 41(4): 135−138.
    [15]
    刘海娟, 刘利娟, 郑素月, 等. 白灵菇液体发酵条件优化[J]. 北方园艺,2021(18):125−131. [LIU H J, LIU L J, ZHENG S Y, et al. Optimization of fermentation conditions for liquid spawn of Pleurotus nebrodensis[J]. Northern Horticulture,2021(18):125−131.]

    LIU H J, LIU L J, ZHENG S Y, et al. Optimization of fermentation conditions for liquid spawn of Pleurotus nebrodensis[J]. Northern Horticulture, 2021(18): 125−131.
    [16]
    李琪琪, 李天歌, 焦颖泽, 等. 具有DPP-Ⅳ抑制活性的酪蛋白糖肽分离纯化及其序列鉴定[J]. 中国乳品工业,2022,50(8):4−8,34. [LI Q Q, LI T G, JIAO Y Z, et al. Preparation and identification of casein glycopeptide with Dipeptidyl Peptidase-IV inhibitory activity[J]. China Dairy Industry,2022,50(8):4−8,34.]

    LI Q Q, LI T G, JIAO Y Z, et al. Preparation and identification of casein glycopeptide with Dipeptidyl Peptidase-IV inhibitory activity[J]. China Dairy Industry, 2022, 50(8): 4−8,34.
    [17]
    付姝颖. 基于骨骼肌和下丘脑转录组的急性运动改善GK大鼠高血糖的调控研究[D]. 广州:华南理工大学, 2022. [FU S Y. The regulatory study of acute exercise alleviating hyperglycemia in GK rats based on skeletal muscle and hypothalamic transcriptome[D]. Guangzhou:South China University of Technology, 2022.]

    FU S Y. The regulatory study of acute exercise alleviating hyperglycemia in GK rats based on skeletal muscle and hypothalamic transcriptome[D]. Guangzhou: South China University of Technology, 2022.
    [18]
    侯清涛, 李芸, 李舍予, 等. 全球糖尿病疾病负担现状[J]. 中国糖尿病杂志,2016,24(1):92−96. [HOU Q T, LI Y, LI S Y, et al. The global burden of diabetes mellitus[J]. Chinese Journal of Diabetes,2016,24(1):92−96.] doi: 10.3969/j.issn.1006-6187.2016.01.023

    HOU Q T, LI Y, LI S Y, et al. The global burden of diabetes mellitus[J]. Chinese Journal of Diabetes, 2016, 24(1): 92−96. doi: 10.3969/j.issn.1006-6187.2016.01.023
    [19]
    郑尔昌, 邹金串, 薛成斌, 等. 糖尿病联合并发症发病风险计算与预测[J]. 华侨大学学报(自然科学版),2022,43(4):498−510. [ZHENG E C, ZOU J C, XUE C B, et al. Risk calculation and prediction of diabetes combined complications incidence[J]. Journal of Huaqiao University (Natural Science),2022,43(4):498−510.] doi: 10.11830/ISSN.1000-5013.202110012

    ZHENG E C, ZOU J C, XUE C B, et al. Risk calculation and prediction of diabetes combined complications incidence[J]. Journal of Huaqiao University (Natural Science), 2022, 43(4): 498−510. doi: 10.11830/ISSN.1000-5013.202110012
    [20]
    郑敏, 李东密. 糖尿病心脏病的中药及其制备研究进展[J]. 广东化工,2023,50(20):62−63,71. [ZHENG M, LI D M. Research progress of chinese herbal and preparation method on the diabetic heat disease[J]. Guangdong Chemical Industry,2023,50(20):62−63,71.] doi: 10.3969/j.issn.1007-1865.2023.20.021

    ZHENG M, LI D M. Research progress of chinese herbal and preparation method on the diabetic heat disease[J]. Guangdong Chemical Industry, 2023, 50(20): 62−63,71. doi: 10.3969/j.issn.1007-1865.2023.20.021
    [21]
    MA C Y, LUO Y M, ZHANG T Y, et al. Predicting coronary heart disease in Chinese diabetics using machine learning[J]. Computers in Biology and Medicine,2024,169:107952. doi: 10.1016/j.compbiomed.2024.107952
    [22]
    柯爽, 李小娟. 从络论治消渴胸痹[J]. 实用中医内科杂志,2020,34(3):108−111. [KE S, LI X J. Treatment of xiaoke and chest painful impediment by collateral theory[J]. Journal of Practical Tradiyional Chinese Internal Medicine,2020,34(3):108−111.]

    KE S, LI X J. Treatment of xiaoke and chest painful impediment by collateral theory[J]. Journal of Practical Tradiyional Chinese Internal Medicine, 2020, 34(3): 108−111.
    [23]
    YE Shiren, YE Jiangnan, YE Xinhua, et al. Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers[J]. Diabetes Research and Clinical Practice,2024,209:111560. doi: 10.1016/j.diabres.2024.111560
    [24]
    王东, 陈庭燕, 周坤, 等. 糖化白蛋白与糖化血红蛋白对2型糖尿病患者冠状动脉疾病的影响分析[J]. 解放军医药杂志,2018,30(3):31−34. [WANG D, CHEN T Y, ZHOU K, et al. Effect analysis between glycated albumin and glycosylated hemoglobin on coronary artery diseasa in patiens with Type 2 Diabetes Mellitus[J]. Medical & Pharmaceutical Journal of Chinese People's Liberation Army,2018,30(3):31−34.] doi: 10.3969/j.issn.2095-140X.2018.03.008

    WANG D, CHEN T Y, ZHOU K, et al. Effect analysis between glycated albumin and glycosylated hemoglobin on coronary artery diseasa in patiens with Type 2 Diabetes Mellitus[J]. Medical & Pharmaceutical Journal of Chinese People's Liberation Army, 2018, 30(3): 31−34. doi: 10.3969/j.issn.2095-140X.2018.03.008
    [25]
    GHOSH N, FENTON S, VAN HOUT I, et al. Therapeutic knockdown of miR-320 improves deteriorated cardiac function in a pre-clinical model of non-ischemic diabetic heart disease[J]. Molecular Therapy - Nucleic Acids,2022,29:330−342. doi: 10.1016/j.omtn.2022.07.007
    [26]
    高菲菲, 高晟, 韩秀江, 等. 糖尿病性心脏病188例中医证候初步研究[J]. 内蒙古中医药,2023,42(5):152−154. [GAO F F, GAO S, HAN X J, et al. Preliminary study on tcm syndromes of 188 cases of diabetes heart disease[J]. Inner Mongolia of Traditional Chinese Medicine,2023,42(5):152−154.]

    GAO F F, GAO S, HAN X J, et al. Preliminary study on tcm syndromes of 188 cases of diabetes heart disease[J]. Inner Mongolia of Traditional Chinese Medicine, 2023, 42(5): 152−154.
    [27]
    FENG H, ZHANG S, WAN J M F, et al. Polysaccharides extracted from Phellinus linteus ameliorate high-fat high-fructose diet induced insulin resistance in mice[J]. Carbohydrate Polymers,2018,200:144−153. doi: 10.1016/j.carbpol.2018.07.086
    [28]
    HU T, LIN Q L, GUO T, et al. Polysaccharide isolated from Phellinus linteus mycelia exerts anti-inflammatory effects via MAPK and PPAR signaling pathways[J]. Carbohydrate Polymers,2018,200:487−497. doi: 10.1016/j.carbpol.2018.08.021
    [29]
    王朝瑞. 桑黄对糖尿病大鼠的干预效果及骨骼肌转录组学分析[D]. 武汉:华中农业大学, 2021. [WANG C R. Phellinus linteus intervention effect on diabetic rats and skeletal muscle transcriptomics analysis[D]. Wuhan:Huazhong Agricultural University, 2021.]

    WANG C R. Phellinus linteus intervention effect on diabetic rats and skeletal muscle transcriptomics analysis[D]. Wuhan: Huazhong Agricultural University, 2021.
    [30]
    刘梦凡, 殷朝敏, 张琪, 等. 比较3种杨树桑黄提取物体外抗氧化、降血糖和抑菌活性[J]. 食品安全质量检测学报,2024,15(3):18−25. [LIU M F, YIN C M, ZHANG Q, et al. Comparison of in vitro antioxidant, hypoglycemic and antibacterial activities of different extracts from 3 kinds of Sanghuangporus vaninii[J]. Journal of Food Safety and Quality,2024,15(3):18−25.]

    LIU M F, YIN C M, ZHANG Q, et al. Comparison of in vitro antioxidant, hypoglycemic and antibacterial activities of different extracts from 3 kinds of Sanghuangporus vaninii[J]. Journal of Food Safety and Quality, 2024, 15(3): 18−25.
    [31]
    王皓, 刘迪, 陈功鑫, 等. 桑黄发酵培养不同时期菌丝体胞内单糖组成比较[J]. 中国食用菌,2021,40(4):61−67,74. [WANG H, LIU D, CHEN G X, et al. Comparative research on monosaccharide composition of Sanghuangporus vaninii in different fermentation periods[J]. Edible Fungi of China,2021,40(4):61−67,74.]

    WANG H, LIU D, CHEN G X, et al. Comparative research on monosaccharide composition of Sanghuangporus vaninii in different fermentation periods[J]. Edible Fungi of China, 2021, 40(4): 61−67,74.
    [32]
    蒋洁莹, 刘瑾. 鬼箭羽对糖尿病大鼠心肌组织氧化应激损伤及NFE2L2/HMOX1信号通路的影响[J]. 中医药导报,2022,28(11):6−11. [JIANG J Y, LIU J. Effects of guijianyu (euonymi ramulus) on oxidative stress injury and NFE2L2/HMOX1 signaling pathway in myocardial tissue of diabetes mellitus rats[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy,2022,28(11):6−11.]

    JIANG J Y, LIU J. Effects of guijianyu (euonymi ramulus) on oxidative stress injury and NFE2L2/HMOX1 signaling pathway in myocardial tissue of diabetes mellitus rats[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2022, 28(11): 6−11.
    [33]
    吴华英, 邓凯, 李静, 等. 益气活血方调控cAMP/Epac1/Rap1信号改善冠心病气虚血瘀证大鼠实验[J]. 中国实验方剂学杂志,2024,30(18):107−116. [WU H Y, DENG K, LI J, et al. Effect of Yiqi huoxue prescription on cAMP/Epac1/Rap1 signaling pathway in rats with qi deficiency and blood stasis syndrome of coronary heart disease[J]. Chinese Journal of Experimental Traditional Medical Formulae,2024,30(18):107−116.]

    WU H Y, DENG K, LI J, et al. Effect of Yiqi huoxue prescription on cAMP/Epac1/Rap1 signaling pathway in rats with qi deficiency and blood stasis syndrome of coronary heart disease[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(18): 107−116.
    [34]
    刘颖. 桑黄通泻方对2型糖尿病模型大鼠心肌损伤的保护作用及机制[D]. 唐山:华北理工大学, 2023. [LIU Y. Protective effect and mechanism of Sanghuang Tongxie Formula on myocardial injury in type 2 diabetes model rats[D]. Tangshan:North China University of Science and Technology, 2023.]

    LIU Y. Protective effect and mechanism of Sanghuang Tongxie Formula on myocardial injury in type 2 diabetes model rats[D]. Tangshan: North China University of Science and Technology, 2023.
    [35]
    黄荣江, 辛文彬, 倪向敏, 等. 外用鱼油促进2型糖尿病大鼠伤口创面的愈合[J]. 陆军军医大学学报,2024,46(6):535−543. [HUANG R J, XIN W B, NI X M, et al. Topical fish oil accelerates wound healing in rats with Type 2 Diabetes Mellitus[J]. Journal of Army Medical University,2024,46(6):535−543.]

    HUANG R J, XIN W B, NI X M, et al. Topical fish oil accelerates wound healing in rats with Type 2 Diabetes Mellitus[J]. Journal of Army Medical University, 2024, 46(6): 535−543.
    [36]
    吴睿婷, 付王威, 万敏, 等. 黑灵芝多糖对糖尿病大鼠血糖血脂调节及肠道菌群的影响[J]. 食品科学,2022,43(5):91−102. [WU R T, FU W W, WAN M, et al. Effect of polysaccharide from Ganoderma atrum on hyperglycemia, blood lipid and gut microbiota of diabetic rats[J]. Food Science,2022,43(5):91−102.] doi: 10.7506/spkx1002-6630-20201203-046

    WU R T, FU W W, WAN M, et al. Effect of polysaccharide from Ganoderma atrum on hyperglycemia, blood lipid and gut microbiota of diabetic rats[J]. Food Science, 2022, 43(5): 91−102. doi: 10.7506/spkx1002-6630-20201203-046
    [37]
    HUI Y H, HUANG N H, EBBERT L, et al. Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs[J]. Journal of Pharmacological and Toxicological Methods,2007,56(2):256−264. doi: 10.1016/j.vascn.2007.05.006
    [38]
    赵洪强, 时敬爱, 王金权, 等. 大豆异黄酮调节Nrf2/HO-1信号通路对多囊卵巢综合征大鼠卵巢组织损伤的影响[J]. 中国药学杂志,2023,58(8):699−707. [ZHAO H Q, SHI J A, WANG J Q, et al. Impact of soy isoflavones on ovarian tissue damage in rats with polycystic ovary syndrome by regula-ting Nrf2/HO-1 signaling pathway[J]. Chinese Pharmaceutical Journal,2023,58(8):699−707.] doi: 10.11669/cpj.2023.08.007

    ZHAO H Q, SHI J A, WANG J Q, et al. Impact of soy isoflavones on ovarian tissue damage in rats with polycystic ovary syndrome by regula-ting Nrf2/HO-1 signaling pathway[J]. Chinese Pharmaceutical Journal, 2023, 58(8): 699−707. doi: 10.11669/cpj.2023.08.007
    [39]
    胡涛. 桑黄多糖抗炎与降脂功能的评估及其分子机理研究[D]. 长沙:中南林业科技大学, 2020. [HU T. The anti-inflammation and lipid-lowering effects and the potential molecular mechanism of Phellinus linteus[D]. Changsha:Central South University of Forestry and Technology, 2020.]

    HU T. The anti-inflammation and lipid-lowering effects and the potential molecular mechanism of Phellinus linteus[D]. Changsha: Central South University of Forestry and Technology, 2020.
    [40]
    程教擘, 李延啸, 王楠楠, 等. 瓜尔豆胶甘露寡糖对链脲佐菌素诱导2型糖尿病小鼠的降血糖作用[J]. 食品科学:2024, 45(16):113−120. [CHENG J B, LI Y X, WANG N N, et al. Hypoglycemic effect of guar gum manno-oligosaccharides on streptozotocin-induced diabetic mice[J]. Food Science, 2024, 45(16):113−120.]

    CHENG J B, LI Y X, WANG N N, et al. Hypoglycemic effect of guar gum manno-oligosaccharides on streptozotocin-induced diabetic mice[J]. Food Science, 2024, 45(16): 113−120.
    [41]
    郑马亮, 徐燕琴, 叶晶珠, 等. 大黄黄连泻心汤治疗2型糖尿病临床研究[J]. 光明中医,2023,38(24):4819−4822. [ZHENG M L, XU Y Q, YE J Z, et al. Dahuang huanglian xiexin decoction in the treatment of Type 2 Diabetes Mellitus[J]. Guangming Journal of Chinese Medicine,2023,38(24):4819−4822.] doi: 10.3969/j.issn.1003-8914.2023.24.033

    ZHENG M L, XU Y Q, YE J Z, et al. Dahuang huanglian xiexin decoction in the treatment of Type 2 Diabetes Mellitus[J]. Guangming Journal of Chinese Medicine, 2023, 38(24): 4819−4822. doi: 10.3969/j.issn.1003-8914.2023.24.033
    [42]
    杜樱洁, 冶岱蔚. 千金黄连丸及其拆方治疗2型糖尿病胰岛素抵抗的实验研究[J]. 新疆中医药,2012,30(4):6−9. [DU Y J, YE D W. Experimental study on Qianjin Huanglian Pill and its decomposed prescription in the treatment of insulin resistance in Type 2 diabetes Mellitus[J]. Xinjiang Journal of Traditional Chinese Medicine,2012,30(4):6−9.] doi: 10.3969/j.issn.1009-3931.2012.04.002

    DU Y J, YE D W. Experimental study on Qianjin Huanglian Pill and its decomposed prescription in the treatment of insulin resistance in Type 2 diabetes Mellitus[J]. Xinjiang Journal of Traditional Chinese Medicine, 2012, 30(4): 6−9. doi: 10.3969/j.issn.1009-3931.2012.04.002
    [43]
    张琳, 董鹏, 李友芳, 等. 口服葡萄糖耐量试验负荷后1小时血糖筛查糖调节受损和糖尿病的最佳切点值及糖调节受损患者转归的随访研究[J]. 现代生物医学进展,2023,23(19):3642−3645,3677. [ZHANG L, DONG P, LI Y F, et al. The best cut-off point value of impaired glucose regulation and diabetes in blood glucose screening 1 h after oral glucose tolerance test loading and the follow-up study of patients with impaired glucose regulation[J]. Progress in Modern Biomedicine,2023,23(19):3642−3645,3677.]

    ZHANG L, DONG P, LI Y F, et al. The best cut-off point value of impaired glucose regulation and diabetes in blood glucose screening 1 h after oral glucose tolerance test loading and the follow-up study of patients with impaired glucose regulation[J]. Progress in Modern Biomedicine, 2023, 23(19): 3642−3645,3677.
    [44]
    黄雨澄, 董爱梅, 黄有媛, 等. 口服葡萄糖耐量试验中1小时血糖升高的意义研究进展[J]. 中国全科医学,2022,25(35):4468−4472. [HUANG Y C, DONG A M, HUANG Y Y, et al. A review on the significance of elevated 1-hour post-load plasma glucose during the oral glucose tolerance test[J]. Chinese General Practice,2022,25(35):4468−4472.]

    HUANG Y C, DONG A M, HUANG Y Y, et al. A review on the significance of elevated 1-hour post-load plasma glucose during the oral glucose tolerance test[J]. Chinese General Practice, 2022, 25(35): 4468−4472.
    [45]
    刘肖肖, 李强, 何洪波, 等. 通过口服葡萄糖耐量试验估算平均血糖的数学模型[J]. 第三军医大学学报,2021,43(21):2389−2394. [LIU X X, LI Q, HE H B, et al. A mathematical model to estimate mean blood glucose by oral glucose tolerance test[J]. Journal of Army Medical University,2021,43(21):2389−2394.]

    LIU X X, LI Q, HE H B, et al. A mathematical model to estimate mean blood glucose by oral glucose tolerance test[J]. Journal of Army Medical University, 2021, 43(21): 2389−2394.
    [46]
    高伟华, 刘鹭, 王芬, 等. 乳酸菌对高糖高脂2型糖尿病小鼠血脂的影响[J]. 食品科学,2019,40(9):179−187. [GAO W H, LIU L, WANG F, et al. Effect of Lactobacillus on blood lipids in Type 2 Diabetic Mice fed High-Glucose and High-Fat Diet[J]. Food Science,2019,40(9):179−187.] doi: 10.7506/spkx1002-6630-20180122-296

    GAO W H, LIU L, WANG F, et al. Effect of Lactobacillus on blood lipids in Type 2 Diabetic Mice fed High-Glucose and High-Fat Diet[J]. Food Science, 2019, 40(9): 179−187. doi: 10.7506/spkx1002-6630-20180122-296
    [47]
    TRITSCHLER S, THEIS F J, LICKERT H, et al. Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas[J]. Molecular Metabolism,2017,6(9):974−990. doi: 10.1016/j.molmet.2017.06.021
    [48]
    GU X M, SHI Y J, CHEN X J, et al. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress[J]. Phytomedicine,2020,78:153319. doi: 10.1016/j.phymed.2020.153319
    [49]
    DING T Q, WEN B, CHEN J, et al. Excess homocysteine inhibits pancreatic β-cell secretory function by repressing Zbtb20 expression[J]. Molecular and Cellular Endocrinology,2024,586:112195. doi: 10.1016/j.mce.2024.112195
    [50]
    魏柯健, 俞静静, 苏洁, 等. 探讨保元汤加减方通过AMPK/SIRT1/PGC-1α通路对小鼠的抗疲劳作用[J]. 北京中医药大学学报,2023,46(12):1716−1727. [WEI K J, YU J J, SU J, et al. Study on the anti-fatigue effect of modified Baoyuan Decoction through the AMPK/SIRT1/PGC-1α pathway[J]. Journal of Beijing University of Traditional Chinese Medicine,2023,46(12):1716−1727.] doi: 10.3969/j.issn.1006-2157.2023.12.012

    WEI K J, YU J J, SU J, et al. Study on the anti-fatigue effect of modified Baoyuan Decoction through the AMPK/SIRT1/PGC-1α pathway[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(12): 1716−1727. doi: 10.3969/j.issn.1006-2157.2023.12.012
    [51]
    FARIA A, PERSAUD S J. Cardiac oxidative stress in diabetes:Mechanisms and therapeutic potential[J]. Pharmacology & Therapeutics,2017,172:50−62.
    [52]
    YANG T G, ZHANG D Q. Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury[J]. Ageing Research Reviews,2023,86:101884. doi: 10.1016/j.arr.2023.101884
  • Other Related Supplements

Catalog

    Article Metrics

    Article views (46) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return